VF
CGTX icon

Virtu Financial’s Cognition Therapeutics CGTX Stock Holding History

Virtu Financial’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96K Buy
83,434
+13,272
+19% +$15.7K ﹤0.01% 1115
2026
Q1 		$53K Buy
70,162
+30,174
+75% +$35.1K ﹤0.01% 1279
2025
Q4 		$54K Buy
+39,988
New +$64.9K ﹤0.01% 1294
2025
Q1 		– Sell
-80,180
Closed -$56K – 1429
2024
Q4 		$56K Buy
80,180
+22,949
+40% +$11.3K ﹤0.01% 1142
2024
Q3 		$27K Buy
+57,231
New +$59K ﹤0.01% 1096
2024
Q1 		– Sell
-11,347
Closed -$21K – 1480
2023
Q4 		$21K Buy
+11,347
New +$15K ﹤0.01% 1314

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.17B AUM 42.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.47B AUM 18.73% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Virtu Financial's CGTX Position: Q2 2026 in Review

Virtu Financial increased its Cognition Therapeutics (CGTX) stake by 19% in Q2 2026, buying an estimated $15.7K and bringing the position to 83,434 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

Virtu Financial first reported a position in CGTX in Q4 2023 and has held it in 6 quarters since. 66 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.

  • Virtu Financial held 83,434 shares of Cognition Therapeutics worth $96K as of Q2 2026.
  • Virtu Financial bought 13,272 Cognition Therapeutics shares in Q2 2026, an estimated $15.7K.
  • Cognition Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1115 holding.
  • Virtu Financial first reported a position in Cognition Therapeutics in Q4 2023 and has held it in 6 quarters since.
  • 66 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.